An FDA panel has voted 17 to 0 to recommend accelerated approval of Intercept Pharmaceuticals Inc.’s (ICPT) Ocaliva (obeticholic acid) for the treatment of patients with primary biliary cirrhosis, recently renamed primary biliary cholangitis.
Forex – financial instrument.Forex news
An FDA panel has voted 17 to 0 to recommend accelerated approval of Intercept Pharmaceuticals Inc.’s (ICPT) Ocaliva (obeticholic acid) for the treatment of patients with primary biliary cirrhosis, recently renamed primary biliary cholangitis.